ArticleMicroorganisms2025
Experience in Implementing Colonization Screening in a Multidisciplinary County Clinical Hospital in Romania.
Article in Microorganisms, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Article
- Evaluation of PhenoMATRIX® PLUS for the culture-based rectal screening of CPOs, ESBL-E,Frontiers in microbiology · 2025Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Skin microbiota plays a crucial role in host defense. Disruptions in this balance can lead to systemic infections. Colonization by pathogenic microorganisms significantly increases the risk of symptomatic infections, prolongs hospital stays and increases healthcare costs. In Romania, the widespread misuse of antibiotics in the community further complicates the management of bacterial resistance, emphasizing the need for proactive measures. Our institution implemented a comprehensive multi-body-site colonization screening protocol starting from January 2024 until June 2024. The screening targeted high-risk patients, including those in ICUs, Oncology, and Hematology Clinics, and individuals with prior hospitalizations, antibiotic use, or medical devices. This study aimed to investigate the prevalence of colonization by multidrug-resistant organisms upon hospital admission and assess the changes in colonization rates during hospitalization. Samples from nasal, axillary, inguinal, and rectal swabs were processed on specialized chromogenic media to detect multidrug-resistant organisms such as methicillin-resistant
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.